Universe Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2025-12-31 |
|---|---|---|
Revenue | $9,036 | $8,705 |
Gross Profit | 3,226 | 3,136 |
EBITDA | -1,268 | -36 |
EBIT | -1,500 | -284 |
Net Income | -1,554 | -387 |
Net Change In Cash | 9,036 | 8,705 |
Free Cash Flow | -4,609 | -7,783 |
Cash | 27,559 | 33,592 |
Basic Shares | 563 | 563 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $17,858 | $23,024 | $32,308 | $40,143 |
Gross Profit | 6,301 | 6,071 | 10,315 | 21,891 |
EBITDA | -2,922 | -3,184 | -6,397 | |
EBIT | -3,440 | -8,019 | -3,692 | -6,931 |
Net Income | -3,672 | -8,727 | -6,163 | -8,736 |
Net Change In Cash | 17,858 | 23,024 | 32,308 | 40,143 |
Free Cash Flow | -5,399 | -9,869 | 1,075 | -1,406 |
Cash | 33,592 | 29,497 | 5,285 | 5,711 |
Basic Shares | 3 | 39 | 5 | 5 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$9.44 |
2025-03-31 | $0 |
2024-06-30 | $0 |
2022-12-31 | -$0.48 |